Vaccines

Primary tabs

Thu, 2015-01-08 20:48 — mdmcdonald

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Kathy Gilbeaux

mdmcdonald

MDMcDonald_me_com

mike kraft

Subscribe to group

Email address for group

vaccines_global@m.resiliencesystem.org

Large study shows safety of COVID mRNA vaccines in young children

Wed, 2023-06-07 10:15 — mike kraft

Large study shows safety of COVID mRNA vaccines in young children CIDRAP

Messenger RNA vaccines for COVID-19 pose little risk to young children, with no myocarditis (inflammation of heart muscle) or pericarditis (inflammation around the heart) observed in vaccine recipients age 0 to 4. The reassuring findings were published today in Pediatrics.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Large study shows safety of COVID mRNA vaccines in young children
Log in or register to post comments

Vaccine news: EU reglators back Covid vaccine update, Novavax touts new shot

Tue, 2023-06-06 10:01 — mike kraft

EU regulators back WHO's COVID vaccine update recommendation Europe's medicine regulators on Tuesday backed the World Health Organization's recommendation to update the antigen composition of COVID-19 vaccines to target one of the currently dominant XBB variants ahead of the upcoming autumn vaccination campaign. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Vaccine news: EU reglators back Covid vaccine update, Novavax touts new shot
Log in or register to post comments

Analysis: Covid disputes made it nearly impossible to pass new vaccine rules in some states

Mon, 2023-06-05 10:33 — mike kraft

How Covid made it nearly impossible to pass new vaccine rules Around the country, vaccine policy is on hold while lawmakers recover from a pandemic-policy hangover. POLITICO

...

Toxic, pandemic-era battles over immunizations and school closures have made vaccine politics radioactive, even on diseases wholly unrelated to Covid-19. In California, where lawmakers pushed through some of the nation’s strictest mandates through 2019, schools are wary of wading back into the fight.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Situation Report

Read more about Analysis: Covid disputes made it nearly impossible to pass new vaccine rules in some states
Log in or register to post comments

FDA approves Pfizer RSV vaccine for older adults

Wed, 2023-05-31 19:38 — mike kraft

FDA approves Pfizer RSV vaccine for older adults The Food and Drug Administration (FDA) on Wednesday approved Pfizer’s vaccine to prevent the respiratory disease RSV in older adults, the company announced. After decades without any RSV shot… nweixel The Hill

...

The approval of Pfizer’s Abrysvo marks the second authorized RSV shot for older adults in the U.S. this month, after GlaxoSmithKline (GSK) won approval for its rival shot, Arexvy.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA approves Pfizer RSV vaccine for older adults
Log in or register to post comments

Antibodies spiked then waned after Pfizer, Moderna COVID vaccines, but J&J response was opposite

Tue, 2023-05-09 18:06 — mike kraft

Antibodies spiked then waned after Pfizer, Moderna COVID vaccines, but J&J response was opposite CIDRAP

...

One month after COVID-19 vaccination, compared with J&J recipients, nAB levels were 51 times higher among Moderna recipients and 21 times higher among Pfizer recipients. At 6 months, however, J&J vaccinees produced the same antibody response as that of Moderna and significantly higher concentrations than those of Pfizer.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Antibodies spiked then waned after Pfizer, Moderna COVID vaccines, but J&J response was opposite
Log in or register to post comments

China's CanSinoBIO's inhaled COVID booster reported stronger against BA.1 Omicron subvariant than Sinovac shot

Tue, 2023-05-09 10:21 — mike kraft

CanSinoBIO's inhaled COVID booster stronger against BA.1 Omicron subvariant than Sinovac shot Chinese vaccine firm CanSino Biologic's inhalation-based candidate elicited a better antibody response as a booster against the BA.1 Omicron sub-variant than Sinovac's shot, but the antibody level dropped in months, clinical trial data showed. Reuters R

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Immune cells—not antibodies—cause rare cases of COVID vaccine-linked myocarditis --study

Mon, 2023-05-08 17:40 — mike kraft

Study: Immune cells—not antibodies—cause COVID vaccine-linked myocarditis The rare cases of myocarditis among recipients of mRNA vaccines are caused by a generalized immune-cell and inflammatory response, researchers say. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Immune cells—not antibodies—cause rare cases of COVID vaccine-linked myocarditis --study
Log in or register to post comments

Paxlovid slashed risk of COVID hospital stay in unvaccinated patients -- Canadian study

Mon, 2023-05-08 17:12 — mike kraft

Paxlovid slashed risk of COVID hospital stay in some patients amid Omicron, study suggests CIDRAP

The antiviral drug Paxlovid was tied to a 96% lower relative risk (RR) of COVID-19 hospitalization among high-risk outpatients who didn't complete a primary vaccination series but didn't benefit those who had received at least two doses amid the SARS-CoV-2 Omicron variant, according to a real-world study published yesterday in Clinical Infectious Diseases.

....

Country / Region Tags:

General Topic Tags: